These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28451983)

  • 1. Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).
    Sala V; Margaria JP; Murabito A; Morello F; Ghigo A; Hirsch E
    Curr Heart Fail Rep; 2017 Jun; 14(3):187-196. PubMed ID: 28451983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ
    Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.
    Marcun R; Stankovic I; Vidakovic R; Farkas J; Kadivec S; Putnikovic B; Ilic I; Neskovic AN; Lainscak M
    Intern Emerg Med; 2016 Jun; 11(4):519-27. PubMed ID: 26423072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in HFpEF: Key or circumstantial?
    van Empel V; Brunner-La Rocca HP
    Int J Cardiol; 2015; 189():259-63. PubMed ID: 25897922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
    Shah KS; Fang JC
    Curr Hypertens Rep; 2019 Oct; 21(11):86. PubMed ID: 31599363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
    Kozaily E; Akdogan ER; Dorsey NS; Tedford RJ
    Curr Hypertens Rep; 2024 Jul; 26(7):291-306. PubMed ID: 38558124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of heart failure with preserved ejection fraction: a review.
    Nanayakkara S; Kaye DM
    Clin Ther; 2015 Oct; 37(10):2186-98. PubMed ID: 26385583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in heart failure with preserved ejection fraction.
    Guazzi M; Gomberg-Maitland M; Arena R
    J Heart Lung Transplant; 2015 Mar; 34(3):273-81. PubMed ID: 25577563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved ejection fraction in hypertension.
    Teo LY; Chan LL; Lam CS
    Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
    Mentz RJ; Kelly JP; von Lueder TG; Voors AA; Lam CS; Cowie MR; Kjeldsen K; Jankowska EA; Atar D; Butler J; Fiuzat M; Zannad F; Pitt B; O'Connor CM
    J Am Coll Cardiol; 2014 Dec; 64(21):2281-93. PubMed ID: 25456761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in heart failure with preserved left ventricular ejection fraction: diagnosis and management.
    Ohara T; Ohte N; Little WC
    Curr Opin Cardiol; 2012 May; 27(3):281-7. PubMed ID: 22450719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do patients with heart failure with preserved ejection fraction die?
    Chan MM; Lam CS
    Eur J Heart Fail; 2013 Jun; 15(6):604-13. PubMed ID: 23610137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Heart Failure with Preserved Ejection Fraction.
    Ilieșiu AM; Hodorogea AS
    Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
    Tannenbaum S; Sayer GT
    Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.
    Agrawal A; Naranjo M; Kanjanahattakij N; Rangaswami J; Gupta S
    Heart Fail Rev; 2019 Jul; 24(4):421-437. PubMed ID: 31127482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.